Solventum Corporation

NYSE (USD): Solventum Corporation (SOLV)

Last Price

68.12

Today's Change

+1.83 (2.76%)

Day's Change

66.70 - 68.72

Trading Volume

152,755

Overview

Market Cap

11 Billion

Shares Outstanding

172 Million

Avg Volume

1,332,457

Avg Price (50 Days)

63.85

Avg Price (200 Days)

60.68

PE Ratio

29.15

EPS

2.34

Earnings Announcement

07-Nov-2024

Previous Close

66.29

Open

66.80

Day's Range

66.705 - 68.72

Year Range

47.16 - 73.4

Trading Volume

156,082

Price Change Highlight

1 Day Change

2.88%

5 Day Change

0.84%

1 Month Change

3.02%

3 Month Change

37.39%

6 Month Change

1.78%

Ytd Change

-14.75%

1 Year Change

-14.75%

3 Year Change

-14.75%

5 Year Change

-14.75%

10 Year Change

-14.75%

Max Change

-14.75%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Healthcare

Description:

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment